Abstract |
Multiple studies suggest increased conversion of cholesterol to bile acids by cholesterol 7alpha-hydroxylase (CYP7A1) protects against dyslipidemia and atherosclerosis. CYP7A1 expression is repressed by the sequential activity of two nuclear hormone receptors, farnesoid X receptor (FXR) and small heterodimer partner (SHP). Here we demonstrate 129 strain SHP(-/-) mice are protected against hypercholesterolemia resulting from either a cholesterol/ cholic acid (chol/CA) diet or from hypothyroidism. In a mixed 129-C57Bl/6 background, LDLR(-/-) and LDLR(-/-)SHP(-/-) mice had nearly identical elevations in hepatic cholesterol content and repression of cholesterol regulated genes when fed a Western diet. However, the LDLR(-/-)SHP(-/-) mice had greatly reduced elevations in serum VLDL and LDL cholesterol levels and triglyceride (TG) levels as compared with LDLR(-/-) mice. Additionally, the hepatic inflammation produced by the Western diet in the LDLR(-/-) mice was abolished in the LDLR(-/-)SHP(-/-) mice. CYP7A1 expression was induced 10-fold by the Western diet in the LDLR(-/-)SHP(-/-) mice but not in the LDLR(-/-) mice. Finally, hepatocyte-specific deletion of SHP expression was also protective against dyslipidemia induced by either a chol/CA diet or by hypothyroidism. While no antagonist ligands have yet been identified for SHP, these results suggest selective inhibition of hepatic SHP expression may provide protection against dyslipidemia.
|
Authors | Helen B Hartman, Kehdih Lai, Mark J Evans |
Journal | Journal of lipid research
(J Lipid Res)
Vol. 50
Issue 2
Pg. 193-203
(Feb 2009)
ISSN: 0022-2275 [Print] United States |
PMID | 18820241
(Publication Type: Journal Article)
|
Chemical References |
- Cholesterol, LDL
- Cholesterol, VLDL
- Receptors, Cytoplasmic and Nuclear
- nuclear receptor subfamily 0, group B, member 2
|
Topics |
- Animals
- Cholesterol, LDL
(blood, metabolism)
- Cholesterol, VLDL
(blood, metabolism)
- Dyslipidemias
(genetics, metabolism)
- Gene Expression
- Liver
(metabolism)
- Mice
- Mice, Transgenic
- Receptors, Cytoplasmic and Nuclear
(genetics, metabolism)
|